Gossamer Bio, Inc. (GOSS)

0.3575 -0.06 (-13.94%) USD  |  NASDAQ  |  Feb 25, 10:46
More

Gossamer Bio Commercial Paper Liability (Quarterly)

Commercial Paper Liability (Quarterly) Chart

View Commercial Paper Liability (Quarterly) for GOSS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Commercial Paper Liability (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Commercial Paper Liability (Quarterly) Range, Past 5 Years

View Commercial Paper Liability (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Commercial Paper Liability (Quarterly) Benchmarks

View Commercial Paper Liability (Quarterly) Benchmarks
Start Trial
Madrigal Pharmaceuticals, Inc. --
XOMA Royalty Corp. --
Rezolute, Inc. --
Axsome Therapeutics, Inc. --
Crinetics Pharmaceuticals, Inc. --